XTLB (XTL Biopharmaceuticals) Float Percentage Of Total Shares Outstanding: 10.35% (As of Jun. 30, 2026)


XTLB XTL Biopharmaceuticals Ltd XTLB
26 GF Score
Price $2.38
! 2 Warning Signs
View Full Analysis

What is XTL Biopharmaceuticals Float Percentage Of Total Shares Outstanding?

XTL Biopharmaceuticals XTLB +0.85% 26 Float Percentage Of Total Shares Outstanding is 10.35% as of Jun. 30, 2026. GuruFocus rates XTLB with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, XTL Biopharmaceuticals's float shares is 0.25 Mil. XTL Biopharmaceuticals's total shares outstanding is 2.37 Mil. XTL Biopharmaceuticals's float percentage of total shares outstanding is 10.35%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, XTL Biopharmaceuticals's Insider Ownership is 0.17%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, XTL Biopharmaceuticals's Institutional Ownership is 3.07%.

XTLB
26GF Score
XTL Biopharmaceuticals Ltd XTLB
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XTL Biopharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

XTL Biopharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.25/2.37
=10.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 10.35% mean?
XTL Biopharmaceuticals (XTLB) has a Float Percentage Of Total Shares Outstanding of 10.35% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on XTL Biopharmaceuticals and its competitors.
Is XTL Biopharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
XTL Biopharmaceuticals' current Float Percentage Of Total Shares Outstanding is 10.35%. Overall, XTL Biopharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does XTL Biopharmaceuticals' Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
XTL Biopharmaceuticals' Float Percentage Of Total Shares Outstanding of 10.35% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on XTL Biopharmaceuticals and its competitors. XTL Biopharmaceuticals's current Float Percentage Of Total Shares Outstanding is 10.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XTL Biopharmaceuticals stock overvalued right now?
XTL Biopharmaceuticals (XTLB) has a current Float Percentage Of Total Shares Outstanding of 10.35%. The current Float Percentage Of Total Shares Outstanding is 10.35%. XTL Biopharmaceuticals' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For XTL Biopharmaceuticals (XTLB), the current Float Percentage Of Total Shares Outstanding is 10.35% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XTL Biopharmaceuticals Business Description

Other Exchanges XTLB:IsraelHHB0:Germany
Address 26 Ben-Gurion Street, Ramat Gan, ISR, 5112001
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
26GF Score

Get the complete analysis for XTLB

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.38
Price